Mouse Nucleoporin 160 kDa (NUP160) Protein

REQUEST MORE INFO
Catalogue No: abx068358
Price: US$275.50
(Size: 10 µg)

Click on the image to see the image legend

Available Options

* Size:






Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Recombinant Nucleoporin 160 kDa (NUP160) is a recombinant Mouse protein produced in a Prokaryotic expression system (E. coli).

Target Nucleoporin 160kDa (NUP160)
Origin Mouse
Expression Recombinant
Tested Applications WB, SDS-PAGE
Host E. coli
Conjugation Unconjugated
Form Lyophilized
Purity > 95%
Reconstitution To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Storage Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.
UniProt Primary AC Q9Z0W3 (UniProt, ExPASy)
UniProt Secondary AC Q3TBI7, Q3TP11, Q3U250, Q6A0A7, Q7TME1, Q9CZD9
UniProt Entry Name NU160_MOUSE
String 10090.ENSMUSP00000059289
Molecular Weight Calculated MW: 25.2 kDa
Sequence Fragment Phe11-Val206
Sequence FVELSGAERE RPRHFREFTV CDIGTASAAF GTVKYSESAG GFYYVESGKL FSITRNRFIH WKTSGDTLEL VEESLDLNLL NNAVRLKFQN YNILPGGVHV SETQNHVIIL ILTNQTVHRL ILPHPSRMYR SELVTESQMQ SIFTDIGKVD FRDPCNSQLI PSVPGLSPGS TTSAAWLSSD GEALFALPSA SGGIFV
Tag N-terminal His tag
Buffer Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.
Activity Not tested
Concentration Prior to lyophilization: 200 µg/ml
Availability Shipped within 5-7 working days.
Note This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Research Articles on Nucleoporin 160kDa (NUP160)


Write a review